GLUCOPHAGE Trademark

Trademark Overview

On Friday, January 21, 2022, a trademark application was filed for GLUCOPHAGE with the United States Patent and Trademark Office. The USPTO has given the GLUCOPHAGE trademark a serial number of 97231961. The federal status of this trademark filing is REGISTERED as of Tuesday, June 25, 2024. This trademark is owned by Merck Santé S.A.S.. The GLUCOPHAGE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the nature of tablets for use in the treatment of diabetes
glucophage

General Information

Serial Number97231961
Word MarkGLUCOPHAGE
Filing DateFriday, January 21, 2022
Status700 - REGISTERED
Status DateTuesday, June 25, 2024
Registration Number7424365
Registration DateTuesday, June 25, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations in the nature of tablets for use in the treatment of diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 26, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Santé S.A.S.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLyon 69008
FR
Party NameMerck Santé S.A.S.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLyon 69008
FR
Party NameMerck Santé S.A.S.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLyon 69008
FR

Trademark Events

Event DateEvent Description
Wednesday, January 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 25, 2022NEW APPLICATION ENTERED
Tuesday, November 1, 2022ASSIGNED TO EXAMINER
Wednesday, November 2, 2022NON-FINAL ACTION WRITTEN
Wednesday, November 2, 2022NON-FINAL ACTION E-MAILED
Wednesday, November 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 2, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 2, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 3, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 17, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 6, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 1, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 1, 2024NOTICE OF ALLOWANCE CANCELLED
Thursday, February 1, 2024TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, February 22, 2024ASSIGNED TO PETITION STAFF
Monday, February 26, 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Monday, February 26, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, February 26, 20241(B) BASIS DELETED; NEW BASIS REQUESTED
Friday, March 1, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, March 7, 2024ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, March 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 25, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 25, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

glucophage treatment diabetes tablets nature preparations pharmaceutical